Survival of studies on allo-SCT versus chemotherapy in pediatric newly diagnosed AML. (A) EFS/DFS for studies analyzed according to the intention-to-treat principle, (B) OS for studies analyzed according to the intention-to-treat principle, and (C) DFS and (D) OS for studies analyzed according to the as-treated principle corrected for time-to-transplantation; n.g. indicates not given. For the BFM98 + Interim98 study, only HR patients were included. The studies are ordered from lowest to highest survival with chemotherapy only.